Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-020824
Filing Date
2024-08-06
Accepted
2024-08-06 16:09:32
Documents
1
Period of Report
2024-08-02

Document Format Files

Seq Description Document Type Size
1 form4-08062024_080827.html 4  
1 form4-08062024_080827.xml 4 4372
  Complete submission text file 0001415889-24-020824.txt   5932
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ADVERUM BIOTECHNOLOGIES, INC. 100 CARDINAL DRIVE REDWOOD CITY CA 94063
Business Address
Seyedkazemi Setareh (Reporting) CIK: 0001903088 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 241179278